2nd Circuit Rejects Antitrust, Lanham Act Claims Involving Drug
NEW YORK — A false advertising and antitrust dispute between two drug makers over the efficacy of tablets and capsules in controlling somnolence — a common side effect for users of...To view the full article, register now.
Already a subscriber? Click here to view full article